Eco R1 Capital, LLC Assembly Biosciences, Inc. Call Options Transaction History

Eco R1 Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $77,074 - $118,014	-17,800 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $7.25 Million - $13 Million	-480,500 Reduced 96.43%	17,800 $293,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $6.43 Million - $10.4 Million	498,300 New	498,300 $6.72 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.